The Story of Acomplia (Rimonabant)
The landmark diet drug Acomplia, has had a path of some ups and downs on the way to market. The drug has received substantial media attention and acclaim after clinical studies demonstrated its unprecedented efficacy and safety as a weight loss medication. These clinical studies have been backed up the thousands of user reports exclaiming delight at the success and weight loss efficacy of the new drug.
Acomplia works through its active ingredient rimonabant. Rimonabant works by decreasing the activity levels of the endo cannabinoid receptor called the CB-1 receptor. By surprising these receptors, people undergoing treatment with Acomplia will feel less hungry. This decrease in appetite allows users of Acomplia to maintain a healthy calorie reduced diet, and when coupled with regular exercise, these users have show impressive weight loss successes.
The drug is taken as one 20 mg tablet daily before breakfast. This drug should be taken as a part of a lifestyle changing diet and exercise modification regimen, to ensure good success.
The drug is not appropriate for women trying to achieve pregnancy, or for expectant mothers. Breast feeding mothers, children, heart disease patients and breast feeding mothers should also not take the weight loss medication.
Before taking the medications, make sure you speak with your doctor, and disclose fully your complete medical history, history of drug and alcohol abuse, and any and all prescription and over the counter medications that you take.
Clinical studies of the medication have revealed further efficacy beyond weight loss. The medication can help you quit smoking, and has been shown to improve metabolic and cardiovascular health, as well as allow people to maintain weight lost while using the medication.
The drug has not had an easy path to success. There have been extensive public and governmental debates surrounding the appropriate usage of the drug. German officials eventually classified the drug as a life style drug. This classification meant that German users would not be eligible for reimbursement for the cost of the drug. Appeals on the classification initiated by the French maker and marketer of the medication, Sanofi-Aventis did not change the legal classification of the drug.
The French drug maker has also been trying hard to have the medication approved for sale by the US FDA. This approval would open an important market for the effective diet drug, but the FDA has been stalling its approval process for unknown reasons.
Regardless of the setbacks, Acomplia has emerged as a very popular drug that does help people lose weight and get healthier. The medication is currently available in many European countries, and the drug can be easily purchased through online pharmacies. Online pharmacies provide convenient access to the medication, a very competitive price, confidential service, and in most cases, over night delivery.
Acomplia has received unprecedented media attention. The public has been captivated by the claimed weight loss successes shown in clinical trials and amongst users of the medication, and public debate on the appropriateness of treatment has kept the medication in the news.
The medication is effective, and if you are overweight can be a great tool in helping you reach your weight loss goals. Buy Acomplia through an online pharmacy for the best possible price and increased convenience.